Nomura Securities Maintains a 'Buy' on Citi (C); Raising FY12 After Q1 Review
Get Alerts C Hot Sheet
Price: $63.24 +0.78%
Rating Summary:
24 Buy, 13 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
24 Buy, 13 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Nomura Securities maintains a 'Buy' on Citi (NYSE: C) price target of $47.00.
Analyst, Glenn Schorr, said, "1Q12 EPS of $1.11 ex-CVA/DVA vs. Our/Street Ests of $1.05/$1.01. Well-rounded quarter with a much better quarter at the IB, continued loan and deposit growth (esp. Asia & LatAm), a flat NIM and decent credit trends combining with good expense control to produce positive operating leverage, good book growth and improving capital ratios. We think Citi’s executing according to plan and the stock is attractive – book is ~$62, tangible book ~$51 and the stock is at 7.6x run-rate earnings. With the CCAR resubmission in process, the 2013 capital return story also remains on track. 2012E EPS goes from $3.90 to $4.70."
For an analyst ratings summary and ratings history on Citi click here. For more ratings news on Citi click here.
Shares of Citi closed at $34.00 yesterday.
Analyst, Glenn Schorr, said, "1Q12 EPS of $1.11 ex-CVA/DVA vs. Our/Street Ests of $1.05/$1.01. Well-rounded quarter with a much better quarter at the IB, continued loan and deposit growth (esp. Asia & LatAm), a flat NIM and decent credit trends combining with good expense control to produce positive operating leverage, good book growth and improving capital ratios. We think Citi’s executing according to plan and the stock is attractive – book is ~$62, tangible book ~$51 and the stock is at 7.6x run-rate earnings. With the CCAR resubmission in process, the 2013 capital return story also remains on track. 2012E EPS goes from $3.90 to $4.70."
For an analyst ratings summary and ratings history on Citi click here. For more ratings news on Citi click here.
Shares of Citi closed at $34.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Home Depot (HD) PT Raised to $360 at Telsey, 'in the long term, Home Depot should remain a winner in retail'
- Canaccord Genuity Reiterates Buy Rating on Aptose Biosciences (APTO)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Citi, Nomura, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!